153 related articles for article (PubMed ID: 28074431)
1. Detection and Specific Elimination of EGFR
Bauerschlag D; Meinhold-Heerlein I; Maass N; Bleilevens A; Bräutigam K; Al Rawashdeh W; Di Fiore S; Haugg AM; Gremse F; Steitz J; Fischer R; Stickeler E; Barth S; Hussain AF
Pharm Res; 2017 Apr; 34(4):696-703. PubMed ID: 28074431
[TBL] [Abstract][Full Text] [Related]
2. Photoimmunotheranostic agents for triple-negative breast cancer diagnosis and therapy that can be activated on demand.
Amoury M; Bauerschlag D; Zeppernick F; von Felbert V; Berges N; Di Fiore S; Mintert I; Bleilevens A; Maass N; Bräutigam K; Meinhold-Heerlein I; Stickeler E; Barth S; Fischer R; Hussain AF
Oncotarget; 2016 Aug; 7(34):54925-54936. PubMed ID: 27448975
[TBL] [Abstract][Full Text] [Related]
3. Fine Tuning Antibody Conjugation Methods using SNAP-tag Technology.
Chouman K; Woitok M; Mladenov R; Kessler C; Weinhold E; Hanz G; Fischer R; Meinhold-Heerlein I; Bleilevens A; Gresch G; Haugg AM; Zeppernick F; Bauerschlag D; Maass N; Stickeler E; Kolberg K; Hussain AF
Anticancer Agents Med Chem; 2017; 17(10):1434-1440. PubMed ID: 28270070
[TBL] [Abstract][Full Text] [Related]
4. A specific photoimmunotheranostics agent to detect and eliminate skin cancer cells expressing EGFR.
von Felbert V; Bauerschlag D; Maass N; Bräutigam K; Meinhold-Heerlein I; Woitok M; Barth S; Hussain AF
J Cancer Res Clin Oncol; 2016 May; 142(5):1003-11. PubMed ID: 26847542
[TBL] [Abstract][Full Text] [Related]
5. The effect of subcellular localization on the efficiency of EGFR-targeted VHH photosensitizer conjugates.
van Lith SAM; van den Brand D; Wallbrecher R; Wübbeke L; van Duijnhoven SMJ; Mäkinen PI; Hoogstad-van Evert JS; Massuger L; Ylä-Herttuala S; Brock R; Leenders WPJ
Eur J Pharm Biopharm; 2018 Mar; 124():63-72. PubMed ID: 29274374
[TBL] [Abstract][Full Text] [Related]
6. The efficient elimination of solid tumor cells by EGFR-specific and HER2-specific scFv-SNAP fusion proteins conjugated to benzylguanine-modified auristatin F.
Woitok M; Klose D; Niesen J; Richter W; Abbas M; Stein C; Fendel R; Bialon M; Püttmann C; Fischer R; Barth S; Kolberg K
Cancer Lett; 2016 Oct; 381(2):323-30. PubMed ID: 27502168
[TBL] [Abstract][Full Text] [Related]
7. Design, Synthesis, and Biological Evaluation of Polyaminocarboxylate Ligand-Based Theranostic Conjugates for Antibody-Targeted Cancer Therapy and Near-Infrared Optical Imaging.
Ren S; Sun X; Wang H; Nguyen TH; Sadeghipour N; Xu X; Kang CS; Liu Y; Xu H; Wu N; Chen Y; Tichauer K; Minh DDL; Chong HS
ChemMedChem; 2018 Dec; 13(24):2606-2617. PubMed ID: 30403833
[TBL] [Abstract][Full Text] [Related]
8. Simultaneous and Independent Dual Site-Specific Self-Labeling of Recombinant Antibodies.
Wollschlaeger C; Meinhold-Heerlein I; Cong X; Bräutigam K; Di Fiore S; Zeppernick F; Klockenbring T; Stickeler E; Barth S; Hussain AF
Bioconjug Chem; 2018 Nov; 29(11):3586-3594. PubMed ID: 30289242
[TBL] [Abstract][Full Text] [Related]
9. One-step site-specific antibody fragment auto-conjugation using SNAP-tag technology.
Hussain AF; Heppenstall PA; Kampmeier F; Meinhold-Heerlein I; Barth S
Nat Protoc; 2019 Nov; 14(11):3101-3125. PubMed ID: 31605098
[TBL] [Abstract][Full Text] [Related]
10. Sortase Enzyme-Mediated Generation of Site-Specifically Conjugated Antibody Drug Conjugates with High In Vitro and In Vivo Potency.
Beerli RR; Hell T; Merkel AS; Grawunder U
PLoS One; 2015; 10(7):e0131177. PubMed ID: 26132162
[TBL] [Abstract][Full Text] [Related]
11. SNAP-tag technology mediates site specific conjugation of antibody fragments with a photosensitizer and improves target specific phototoxicity in tumor cells.
Hussain AF; Kampmeier F; von Felbert V; Merk HF; Tur MK; Barth S
Bioconjug Chem; 2011 Dec; 22(12):2487-95. PubMed ID: 21995499
[TBL] [Abstract][Full Text] [Related]
12. CSPG4 as a target for the specific killing of triple-negative breast cancer cells by a recombinant SNAP-tag-based antibody-auristatin F drug conjugate.
Mungra N; Biteghe FAN; Malindi Z; Huysamen AM; Karaan M; Hardcastle NS; Bunjun R; Chetty S; Naran K; Lang D; Richter W; Hunter R; Barth S
J Cancer Res Clin Oncol; 2023 Oct; 149(13):12203-12225. PubMed ID: 37432459
[TBL] [Abstract][Full Text] [Related]
13. Layer-by-layer assembled fluorescent probes in the second near-infrared window for systemic delivery and detection of ovarian cancer.
Dang X; Gu L; Qi J; Correa S; Zhang G; Belcher AM; Hammond PT
Proc Natl Acad Sci U S A; 2016 May; 113(19):5179-84. PubMed ID: 27114520
[TBL] [Abstract][Full Text] [Related]
14. HER2-targeted antibody drug conjugates for ovarian cancer therapy.
Jiang J; Dong L; Wang L; Wang L; Zhang J; Chen F; Zhang X; Huang M; Li S; Ma W; Xu Q; Huang C; Fang J; Wang C
Eur J Pharm Sci; 2016 Oct; 93():274-86. PubMed ID: 27509865
[TBL] [Abstract][Full Text] [Related]
15. Photosensitizer-conjugated tryptophan-containing peptide ligands as new dual-targeted theranostics for cancers.
Kim J; Chae J; Kim JS; Goh SH; Choi Y
Int J Pharm; 2016 Nov; 513(1-2):584-590. PubMed ID: 27686051
[TBL] [Abstract][Full Text] [Related]
16. SNAP-Tag Technology: A Useful Tool To Determine Affinity Constants and Other Functional Parameters of Novel Antibody Fragments.
Niesen J; Sack M; Seidel M; Fendel R; Barth S; Fischer R; Stein C
Bioconjug Chem; 2016 Aug; 27(8):1931-41. PubMed ID: 27391930
[TBL] [Abstract][Full Text] [Related]
17. Dendrimer-encapsulated naphthalocyanine as a single agent-based theranostic nanoplatform for near-infrared fluorescence imaging and combinatorial anticancer phototherapy.
Taratula O; Schumann C; Duong T; Taylor KL; Taratula O
Nanoscale; 2015 Mar; 7(9):3888-902. PubMed ID: 25422147
[TBL] [Abstract][Full Text] [Related]
18. Synthesis, characterization and targeting chemotherapy for ovarian cancer of trastuzumab-SN-38 conjugates.
Yao Y; Yu L; Su X; Wang Y; Li W; Wu Y; Cheng X; Zhang H; Wei X; Chen H; Zhang R; Gou L; Chen X; Xie Y; Zhang B; Zhang Y; Yang J; Wei Y
J Control Release; 2015 Dec; 220(Pt A):5-17. PubMed ID: 26439663
[TBL] [Abstract][Full Text] [Related]
19. EpCAM- and EGFR-Specific Antibody Drug Conjugates for Triple-Negative Breast Cancer Treatment.
Zhang C; Sheng W; Al-Rawe M; Mohiuddin TM; Niebert M; Zeppernick F; Meihold-Heerlein I; Hussain AF
Int J Mol Sci; 2022 May; 23(11):. PubMed ID: 35682800
[TBL] [Abstract][Full Text] [Related]
20. Conjugation effects on antibody-drug conjugates: evaluation of interaction kinetics in real time on living cells.
Bondza S; Stenberg J; Nestor M; Andersson K; Björkelund H
Mol Pharm; 2014 Nov; 11(11):4154-63. PubMed ID: 25252166
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
